Streetbeat News

Equity Actions

AVDE

AVSD

UBS

UBS Group AG announced that AT1 bonds worth ~$5 billion are now available for equity conversion, following a shareholder decision. This covers four AT1 issuances since November 2023. UBS reported Q1 FY24 sales of $12.74 billion and EPS of $0.52, surpassing consensus estimates. The bank also anticipates completing the merger with Credit Suisse AG by May 31. UBS stock has gained over 54% in the past year, and investors can gain exposure through AVDE and AVSD ETFs.

Portfolio Pulse from Lekha Gupta

May 13, 2024 | 2:05 pm

VNO

Analysts have mixed views on Vornado Realty (NYSE:VNO), with recent ratings ranging from bearish to neutral. The average 12-month price target is now $24.67, down from $26.50. Vornado faces revenue challenges, with a -2.14% growth over 3 months, but has strong net margins and ROE. The company's debt-to-equity ratio is high at 2.06, indicating potential financial risks.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 2:00 pm

CLS

NVDA

SMCI

SPY

The article pays tribute to Jim Simons, highlighting his exceptional investment record, particularly with the Medallion Fund, and his contributions to math and science. It also mentions the performance of the SPDR S&P 500 Trust ETF (SPY) and companies like Super Micro Computer, Inc. (SMCI), Celestica (NYSE:CLS), and Nvidia (NASDAQ:NVDA) in the context of a top ten names list from a Substack post.

Portfolio Pulse from David Pinsen

May 13, 2024 | 1:46 pm

PR

Permian Resources announced the pricing of its secondary public offering of 51.765 million shares at $16.47 per share.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 1:38 pm

UMH

Recent analyst ratings for UMH Properties (NYSE:UMH) show a mix of neutral and buy recommendations, with a shift towards a more cautious outlook in the last 30 days. The average 12-month price target has been adjusted to $18.5, marking a 3.9% decrease from the previous $19.25. Analysts from Wedbush and Compass Point, among others, have maintained or raised their ratings, reflecting varied expectations for the company's performance.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 1:00 pm

AMPX

Amprius Technologies, Inc. (AMPX) announced a temporary offer to exercise public and private warrants at a reduced price, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:46 pm

CCLD

CareCloud has announced its decision to retain an investment bank to review and evaluate the terms of its Series A Preferred Stock. The aim is to make recommendations to the board that could benefit both the company and its shareholders.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:46 pm

AMPX

Amprius announces that holders of offering warrants, originally exercisable for one share of common stock at $11.50, will now have the chance to exercise these warrants at a reduced price of $1.10 per warrant for a limited time.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:46 pm

RNAZ

TransCode Therapeutics has issued an open letter to shareholders regarding a proposed reverse stock split to maintain its Nasdaq listing. The company's stock failed to meet the Nasdaq's Minimum Bid Requirement by not closing at $1.00 or more for any ten-day period ended May 6. Nasdaq has recommended delisting, but TransCode plans to appeal this decision at a Nasdaq Panel Hearing. The reverse split is considered a last resort to remain listed, and the company's stock has recently closed above $1.00 for four consecutive days.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:41 pm

GNPX

Genprex has announced the appointment of Jose A. Moreno Toscano as the new Chairman of its Board of Directors. This strategic move aims to leverage Toscano's extensive experience in the pharmaceutical industry to guide Genprex's future growth and development.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:39 pm